Changing the future of Oncology.


Open Letter From Our CEO

Hi All, For several years I have been troubled by the levels of public antipathy (if not outright scorn) for our industry.  Routinely biotech (not just pharma) is held in low esteem by the American public – effectively on a par with the tobacco industry. While I...

read more

Sutro Biopharma Appoints James Panek to Board of Directors

SOUTH SAN FRANCISCO, Calif., Jan. 8, 2020 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation oncology...

read more